Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

DNA-Guided Precision Medicine for Cancer: A Case of Irrational Exuberance?

Cancer discovery - 1 Feb 2016

Voest Emile E, Bernards Rene

Abstract excerpt

Precision treatment with targeted cancer drugs requires the selection of patients who are most likely to benefit from a given therapy. We argue here that the use of a combination of both DNA and transcriptome analyses will significantly improve drug response prediction.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Molecular Targeted Therapy
Share to Neoplasms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Patient Selection

Share to Precision Medicine

Share to Sequence Analysis, DNA

Share to Sequence Analysis, RNA

Share to Treatment Outcome

Source

Identifiers

PMID: 26851184
DOI: 10.1158/2159-8290.CD-15-1321

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

DNA-Guided Precision Medicine for Cancer: A Case of Irrational Exuberance?PMID 26851184Read ↗

Precision medicine in the era of multi-omics: can the data tsunami guide rational treatment decision?Semantic proximity Read ↗

Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trialSemantic proximity Read ↗

Precision oncology: current and future platforms for treatment selection.Semantic proximity Read ↗

Precision cancer medicine: the future is now, only better.Semantic proximity Read ↗

Druggable genome and precision medicine in cancer: current challengesSemantic proximity Read ↗

Precision medicine at Memorial Sloan Kettering Cancer Center: clinical next-generation sequencing enabling next-generation targeted therapy trialsSemantic proximity Read ↗

The Precision Medicine: Advancement and Transformation in Cancer TreatmentSemantic proximity Read ↗

Whole-genome and transcriptome analysis enhances precision cancer treatment options.Semantic proximity Read ↗

Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapySemantic proximity Read ↗

The Future of Precision Oncology.Semantic proximity Read ↗

Precision medicine for cancer with next-generation functional diagnosticsSemantic proximity Read ↗

Next‐Generation Cancer Therapeutics: Revolutionizing Treatment with Precision Medicine and ImmunotherapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.